Evidence is mounting that multiple sclerosis (MS) may be triggered by one of the most common viruses in the world. The ...

Infectious mononucleosis (IM, mono), also known as glandular fever, is an infection usually caused by the Epstein–Barr virus (EBV). Most people are infected by the virus as children, when the disease ...

"After decades of surprising indifference, or even resistance, to mounting and compelling evidence that EBV is required to develop MS, the scientific community is finally catching up with such ...

For decades, researchers have suspected that Epstein-Barr virus (EBV), best known for causing infectious mononucleosis, might also be involved in triggering multiple sclerosis (MS). Recent research ...

November 7, 2011 — An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers, without necessarily preventing ...

Researchers are progressing towards a vaccine against Epstein-Barr virus (EBV), which affects 95% of the global population ...

Feb 25 (Reuters) - Researchers may be closer to developing a vaccine that protects against ‌Epstein-Barr, a common virus ...

EBViously, a spin-off from Helmholtz Munich (HMGU), is led by world-leading experts in Epstein-Barr virus biology, genetics, and immunity and was founded to develop a safe and highly effective ...

Mononucleosis tests can detect antibodies directed to viruses that cause mononucleosis. Usually, a doctor recommends these tests when someone has symptoms of the disease. People often refer to ...

When the Epstein-Barr virus (EBV) infects cells, typically B cells, it relies on a protein called gp42. One part of the protein is involved in receptor binding, and another part is involved in ...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative ...